BREAKING NEWS Medicinal cannabis products to be legalised

Billy Caldwell and Alfie Dingley both have a severe form of epilepsy

Specialist doctors in the UK will be able to legally prescribe cannabis-derived medicinal products by autumn, the home secretary has announced.

Those that meet safety and quality standards are to be made legal for patients with an “exceptional clinical need”, Sajid Javid said.

It follows high-profile cases involving children with severe epilepsy being denied access to cannabis oil.

Others forms of cannabis will remain illegal.

‘Exceptional circumstances’

Mr Javid’s decision was made after the chief medical officer for England, Prof Dame Sally Davies, and the Advisory Council on the Misuse of Drugs said patients with certain medical conditions should be given access to the treatments.

Their advice was part of a review into medicinal cannabis launched by the home secretary following an outcry over Billy Caldwell and Alfie Dingley being denied access to cannabis oil.

The parents of the boys, who have rare forms of epilepsy, say it controls their seizures.

Charlotte and Billy Caldwell

The Home Office recently granted them licences to access the treatments.

Mr Javid said: “Recent cases involving sick children made it clear to me that our position on cannabis-related medicinal products was not satisfactory.

“That is why we launched a review and set up an expert panel to advise on licence applications in exceptional circumstances.

“This will help patients with an exceptional clinical need but is in no way a first step to the legalisation of cannabis for recreational use.”

‘Birthday present’

Billy Caldwell’s mother, Charlotte, said Mr Javid’s announcement had been made on her son’s 13th birthday.

“For the first time in months I’m almost lost for words, other than ‘thank you Sajid Javid’,” she said.

“Never has Billy received a better birthday present, and never from somebody so unexpected…

“But, crucially, my little boy Billy can now live a normal life with his mummy because of the simple ability to now administer a couple of drops a day of a long-maligned but entirely effective natural medication.”

Cannabis is classed as a Schedule 1 drug, meaning it is judged to have no therapeutic value but can be used for the purposes of research with a Home Office licence.

The decision by the Home Office will put certain cannabis-derived products into Schedule 2 – those that have a potential medical use – and will place them in the same category as cocaine and heroin, among other drugs.

The Department for Health and Social Care and the Medicines and Health products Regulatory Agency (MHRA) will now develop a clear definition of what constitutes a cannabis-derived medicinal product so they can be rescheduled and prescribed, the Home Office said.

In the meantime, clinicians will still be able to apply to an independent expert panel on behalf of patients wishing to access these products.

The home secretary said licence fees for applications made to the panel will be waived, and those already granted will not be charged.

‘Safer medicines’

The home secretary’s decision was welcomed by campaigners and health experts.

The Royal College of Nursing said the decision was “very welcome”.

Dr Tom Freeman, senior academic fellow at King’s College London, said Mr Javid’s decision would have a “substantial impact on research by facilitating the development of safer and more effective medicines”.

Former justice minister Sir Mike Penning, who was among those appealing for Alfie Dingley to be given a special licence for medicinal cannabis, welcomed the announcement but said there were still unanswered questions about which treatments would be rescheduled.

“Any move to restrict medical cannabis in the UK to a very narrow range of derived products, each requiring full pharmaceutical trials, thereby blocking out the many products available overseas, will lead to great disappointment and be a missed opportunity.”

https://www.bbc.co.uk/news/health-44968386

Advertisements

Artian CBD at Vapour Shack

https://vapour-shack.com/cat/e-liquids/artisan-cbd/

artisan-flavourless-eliquid-200mg

FLAVOURLESS

You can simply mix our flavourless CBD E-Liquid with your favourite e-liquid to get the wonderful benefits of CBD with the flavour you love, alternatively you can if you prefer vape the e-liquid on its own (straight) it’s up to you.

10ML

Artisan CBD E-Liquids come in a variety of specially crafted flavours ready to use straight out of the bottle, or if you prefer you can simply mix our flavourless CBD E-Liquid with your favourite e-liquid to get the benefits of CBD with the flavour you love.

Contains pure 100% natural plant-derived CBD with a 99+% purity,

blended with70%pg 30%vg

For Use in E-Cigarettes & Vapourizers Only

Suitable for vegetarians, vegans and is gluten free.

artisan-cbd-blueberry-eliquids-groupartisan-cbd-blueberry-eliquid-200mg (1)

BLUEBERRY

A skillfully blended E-liquid featuring rich sun kissed Blueberries, a favourite with many of our customers.

artisan-cbd-menthol-eliquids-groupartisan-menthol-eliquid-300mg

MENTHOL

A wonderful cool fresh flavour on the inhale and leaves you with a pleasant minty sensation on the exhale, perfect for mint lovers.

artisan-cbd-strawberry-eliquids-groupartisan-cbd-strawberry-eliquid-100mg

STRAWBERRY

A burst of freshly picked juicy strawberries, this is perfect if you desire a full flavoured summer fruit sensation.

This is a wholesome simple product just the purest full Spectrum natural whole plant extract blended with refined coconut oil (MCT) and that’s it, no added chemicals, flavouring or synthesized CBD.

Do Not use in Vapourizers or E-Cigarettes!

For our products we use only hemp that is sustainably grown and harvested in Europe. Our Hemp is grown in line with organic guidelines and without the use of chemical fertilizers or pesticides.

To preserve the purity and natural genetics of the raw hemp we use a very gentle low-temperature CO2 extraction technique. This process results in a raw and natural product containing a full-spectrum of cannabinoids, terpenes and flavournoids.  Find out more

Each bottle contains approximately 200 drops

https://vapour-shack.com/cat/e-liquids/artisan-cbd/

 

Smok tfv12 prince cobra edition

TFV12 Prince Cobra Edition tank, an unprecedentedly powerful and beautiful one. It has a cobra mesh inside, when you dripped e-liquid in the tank you can see beautiful liquid fill every part of the cobra mesh! And with snakelike patterns carved on the top and base, the whole tank looks like an exquisite artwork. Its included V12 Prince strip coil is a revolutionary one, having larger heating area and can bring you purer flavor. Besides, acrylic bulb tube and drip tip are included in this kit as extra gifts! Excellent design, powerful new coils, this cobra edition will surprise you! Innovation keeps changing the vaping experience!

10 COLORS AVAILABLE

 

THE KIT INCLUDES

SPECIFICATIONS

COMPONENTS

EXCELLENT ACCESSORY
— COBRA MESH

Cobra Mesh is not only one of the most stable structures but also a beautiful masterpiece.
with it in the tank, the coil can be completely enveloped and when you pour e-liquid in you can see “the shape of e-liquid”!

TFV12 PRINCE COBRA WITH GLOBAL GLASS TUBE

ACRYLIC DRIP TIP & BULB TUBE

Different from the traditional cylindrical drip tips , this new acrylic one has radian on its body,making it more suitable to your mouth. And the acrylic bulb tube has colorful and high-pellucidity appearance, you can clearly see the e-juice through it. More importantly, we use high quality acrylic, which ensures non-toxic and high temperature resistance.

YOU CAN BUY THESE COBRA V2 RESIN DRIP TIPS SEPARATELY!

TFV12 PRINCE CORES

TOP REFILL SYSTEM

Top rotary refill makes filling a easy thing. Leak proof slot can significantly solve leaking problem.

 

NHS hospitals should sell e-cigarettes, says Government agency

Smoking shelters should become “vaping lounges” for less risky e-cigarette use, NHS bosses said

Hospitals should stock e-cigarettes for sale to patients and permit “vaping” in private rooms as part of the NHS ”smoke free” efforts, according to health chiefs.

The call comes from Public Health England, as part of an evidence update on the safety of tobacco alternatives which it says should be used more widely as quitting aids.

Meanwhile, Government officials should help manufacturers licence e-cigarettes as medical quitting aids.

Such a move would allow GPs to prescribe the devices to their patients who are trying to stop smoking.

In the independent review, which updates 2015 guidance, experts concluded that vaping only poses a small fraction of the risks of smoking and could be particularly helpful in mental health hospitals.

These patients are often on a long-term stay, and have high levels of smoking and tobacco related harm which could be mitigated by promoting vaping.

E-cigarettes could be contributing to 20,000 new quits each year, they estimated.

But the number of people using the products has “plateaued” and now stands at just under three million people in the UK, according to the review, which was conducted by experts from King’s College London and the UK Centre for Tobacco and Alcohol Studies, the University of Stirling and Cancer Research UK.

One reason behind the stall in uptake could be misconceptions about the levels of harm linked to the devices.

Researchers found that thousands of smokers “incorrectly” believe that vaping is as harmful as smoking and two in five smokers had not even tried an e-cigarette.

In a linked editorial, published in The Lancet, experts from PHE said: “Although not without risk, the overall risk of harm is estimated at less than 5% of that from smoking tobacco; the risk of cancer has been calculated to be less than 1%.”

PHE officials also warned about the risks of tobacco industry efforts to promote “heat not burn” tobacco products as a safer alternatives to regular cigarettes.

It warns that while these combustion-free alternatives currently appear to have some reduced risk, the majority of the research has been conducted the tobacco industry.

Following the review, PHE has made a number of recommendations about e-cigarettes, including a call for the Medicines and Healthcare products Regulatory Agency to support manufacturers to license the products as medical quit aids so they can be made available on the NHS; encouraging any smoker to switch to using e-cigarettes, and calling on NHS trusts to be “truly smoke free”, and as part of this, ensuring e-cigarettes are for sale in hospital shops.

Martin Dockrell, tobacco control lead for PHE, said: “We are saying no smoking anywhere on the grounds [of hospitals], no smoking in the smoking shelter – that shelter becomes a vaping shelter.

“There are two parts to being a smoke-free hospital, one is not allowing smoking on the premises, the other is helping every smoker to quit.

“Some hospitals will decide, especially with their longer-term patients or patients who don’t have a choice whether they are there or not, where it will be appropriate to have spaces indoors to have spaces where vaping is permitted.

“The strongest case for that is psychiatric hospitals because [these patients] have got the highest prevalence of smoking and the highest levels of smoking related harm.

“Single occupancy rooms are quite common in mental health trusts so that makes it very easy for people to vape in a single occupancy room without any annoyance to anybody else.”

On acute hospitals he added: “It is going to be for each hospital to make their own policy but yes, we would certainly encourage them to make at least some single occupancy rooms where people can vape. Of course smoking is prohibited everywhere.”

When asked about indoor communal rooms for vaping, Mr Dockrell said: “There is no reason why a hospital shouldn’t designate some indoor areas where patients and visitors can vape.”

Professor John Newton, director for health improvement at PHE, said: “Our new review reinforces the finding that vaping is a fraction of the risk of smoking, at least 95% less harmful, and of negligible risk to bystanders.

“Yet over half of smokers either falsely believe that vaping is as harmful as smoking or just don’t know.

“It would be tragic if thousands of smokers who could quit with the help of an e-cigarette are being put off due to false fears about their safety.”

Ann McNeill, lead author and professor of tobacco addiction at King’s College London, said: “It’s of great concern that smokers still have such a poor understanding about what causes the harm from smoking.

“People smoke for the nicotine, but contrary to what the vast majority believe, nicotine causes little if any of the harm.

However pro-smoking groups argued PHE’s endorsement could be enough to keep people smoking tobacco, by making e-cigarettes “just another smoking cessation aid”.

“If that happens they will almost certainly lose their appeal to independent-minded smokers who don’t want the state dictating their behaviour,” said Simon Clark, director of the smokers’ group Forest.